Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on expression of 3...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2018
|
| 在線閱讀: | https://doi.org/10.1186/s13000-018-0690-3 https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/s13000-018-0690-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|